Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE5300.0030.7 (+0.58 %)
PREV CLOSE () 5269.30
OPEN PRICE () 5296.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 254
TODAY'S LOW / HIGH ()5289.10 5371.65
52 WK LOW / HIGH ()3118.55 7208
NSE5332.2547.45 (+0.9 %)
PREV CLOSE() 5284.80
OPEN PRICE () 5321.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5332.25 (2)
VOLUME 3817
TODAY'S LOW / HIGH() 5288.10 5374.00
52 WK LOW / HIGH ()3115.05 7220.95
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1979

Management Info :

Narayan K Seshadri - Chairman Sanjeev Kumar Panchal - Managing Director

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone : 080 6774 8000

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX
NEWS
27Mar AstraZeneca Pharma gets nod to import
AstraZeneca Pharma India has received permission to import for sale and..
27Mar AstraZeneca Pharma surges on getting n
Astrazeneca Pharma India is currently trading at Rs. 5258.00, up by 198...
11Mar AstraZeneca Pharma India, Mankind Phar
AstraZeneca Pharma India and Mankind Pharma have entered into an agreeme..
11Mar Astrazeneca Pharma India informs about
Astrazeneca Pharma India has enclosed copy of press release in connectio..
20Feb AstraZeneca Pharma India informs about
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit158992.929999999999
Gross Profit 203.98 1341.05
Operating Profit 247.161914.27
Net Sales 3057.8910029.71
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddy's Lab (BSE)
 6217.15 (4.47%)
M.Cap ( in Cr)
103713.42
Abbott India (BSE)
 25725.00 (1.03%)
M.Cap ( in Cr)
54663.83
Bharat Parenterals (BSE)
 1701.80 (10.00%)
M.Cap ( in Cr)
990.39
Alkem Laboratories (BSE)
 4857.90 (3.10%)
M.Cap ( in Cr)
58083.48
NGL Fine-Chem (BSE)
 2711.85 (3.47%)
M.Cap ( in Cr)
1675.39
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 18.49%
MUTUAL FUNDS/UTI 3.75%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74339.44486.50 (0.66%)
NIFTY22570.35167.95 (0.75%)
Dow Jones 38460.92-42.77 (-0.11%)
Nasdaq 15712.7516.11 (0.10%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI